J, X., Y, S., Q, H., L, S., J, W., X, H., . . . J, W. (2026). Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia, 219, 278. https://doi.org/10.1016/j.actbio.2026.07.001
Παραπομπή σε μορφή Chicago (17η εκδ.)J, Xu, et al. "Injectable PH-responsive Gelatin Methacryloyl Hydrogel for Cuproptosis-synergized Sunitinib Therapy and Immune Reprogramming in Clear Cell Renal Cell Carcinoma." Acta Biomaterialia 219 (2026): 278. https://doi.org/10.1016/j.actbio.2026.07.001.
Παραπομπή σε μορφή MLA (9th εκδ.)J, Xu, et al. "Injectable PH-responsive Gelatin Methacryloyl Hydrogel for Cuproptosis-synergized Sunitinib Therapy and Immune Reprogramming in Clear Cell Renal Cell Carcinoma." Acta Biomaterialia, vol. 219, 2026, p. 278, https://doi.org/10.1016/j.actbio.2026.07.001.